RXO (NYSE:RXO) Price Target Raised to $20.00 at Susquehanna

RXO (NYSE:RXOFree Report) had its target price raised by Susquehanna from $18.00 to $20.00 in a research report report published on Tuesday, Marketbeat.com reports. Susquehanna currently has a negative rating on the stock.

A number of other analysts have also recently weighed in on the stock. Zacks Research raised shares of RXO from a “strong sell” rating to a “hold” rating in a report on Monday, April 6th. Morgan Stanley restated an “equal weight” rating and issued a $22.00 target price (up from $19.00) on shares of RXO in a research report on Thursday, May 7th. UBS Group raised their price target on shares of RXO from $22.00 to $26.00 and gave the company a “neutral” rating in a research note on Tuesday, June 30th. Barclays lifted their price target on RXO from $20.00 to $28.00 and gave the company an “overweight” rating in a report on Thursday, June 25th. Finally, Wall Street Zen upgraded RXO from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Four research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $23.14.

View Our Latest Research Report on RXO

RXO Stock Up 3.6%

NYSE:RXO opened at $28.07 on Tuesday. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28. The stock has a 50 day moving average of $25.27 and a 200-day moving average of $18.78. The firm has a market capitalization of $4.63 billion, a PE ratio of -46.02 and a beta of 2.03. RXO has a 52 week low of $10.43 and a 52 week high of $29.86.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.09) EPS for the quarter, hitting analysts’ consensus estimates of ($0.09). The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.34 billion. RXO had a negative return on equity of 1.16% and a negative net margin of 1.83%.The firm’s revenue was down .6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.03) EPS. Analysts predict that RXO will post 0.08 EPS for the current year.

Hedge Funds Weigh In On RXO

Several hedge funds have recently modified their holdings of the company. City Holding Co. lifted its holdings in shares of RXO by 227.6% in the second quarter. City Holding Co. now owns 1,245 shares of the company’s stock valued at $34,000 after buying an additional 865 shares during the period. Geneos Wealth Management Inc. bought a new stake in RXO in the first quarter worth about $30,000. Cassaday & Co Wealth Management LLC bought a new stake in RXO in the first quarter worth about $29,000. Flagship Harbor Advisors LLC acquired a new stake in RXO in the 4th quarter valued at about $25,000. Finally, Quarry LP acquired a new stake in RXO in the 3rd quarter valued at about $33,000. 92.73% of the stock is currently owned by institutional investors and hedge funds.

RXO Company Profile

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.